Introduction: Access to rehabilitation services after a traumatic injury improves functional outcomes. No study has examined the association between injury intent, violent versus nonviolent, and receipt of rehabilitation services after injury.
Materials And Methods: We conducted a retrospective cohort study of injured adult patients admitted to our level I trauma center from January 1, 2014 to December 31, 2021.
Double-strand break (DSB) repair is associated with a 1000-fold increase in mutations compared to normal replication of the same sequences. In budding yeast, repair of an HO endonuclease-induced DSB at the α locus can be repaired by using a homologous, heterochromatic donor harboring a transcriptionally silenced gene, resulting in a (Ura) repair product where is expressed. Repair-associated mutations can be selected by resistance to 5-fluoroorotic acid (FOA).
View Article and Find Full Text PDFBackground: We aim to evaluate the safety and efficacy of mistletoe extract (ME) use during the oncological perioperative period.
Methods: Details registered a priori on PROSPERO (CRD42018086168).
Results: Seven RCTs (comprising 663 participants in nine reports) and three nonrandomized studies were included.
We present avidity sequencing, a sequencing chemistry that separately optimizes the processes of stepping along a DNA template and that of identifying each nucleotide within the template. Nucleotide identification uses multivalent nucleotide ligands on dye-labeled cores to form polymerase-polymer-nucleotide complexes bound to clonal copies of DNA targets. These polymer-nucleotide substrates, termed avidites, decrease the required concentration of reporting nucleotides from micromolar to nanomolar and yield negligible dissociation rates.
View Article and Find Full Text PDFGermline pathogenic mutations in BReast CAncer (BRCA1) genes are thought to drive normal fallopian tube epithelial (FTE) cell transformation to high-grade serous ovarian cancer. No human models capture the sequence of events for disease initiation and progression. Here, we generate induced pluripotent stem cells (iPSCs) from healthy individuals and young ovarian cancer patients with germline pathogenic BRCA1 mutations (BRCA1).
View Article and Find Full Text PDF